Author:
Sparidans Rolf W.,Tang Seng Chuan,Nguyen Luan N.,Schinkel Alfred H.,Schellens Jan H.M.,Beijnen Jos H.
Subject
Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development and validation of an ultra‐performance liquid chromatography–tandem mass spectrometry method to quantify the small molecule inhibitors adagrasib, alectinib, brigatinib, capmatinib, crizotinib, lorlatinib, selpercatinib, and sotorasib in human plasma;Biomedical Chromatography;2024-08-13
2. Nanotechnology-based Drug Delivery Systems for the Treatment of Cervical Cancer: A Comprehensive Review;Current Nanoscience;2024-03
3. Crizotinib: A comprehensive profile;Profiles of Drug Substances, Excipients and Related Methodology;2023
4. Recent Upgradation in Bioanalytical Studies;Biosciences Biotechnology Research Asia;2022-03-31
5. Development and validation of UPLC–MS/MS method for the simultaneous quantification of anaplastic lymphoma kinase inhibitors, alectinib, ceritinib, and crizotinib in Wistar rat plasma with application to bromelain-induced pharmacokinetic interaction;Journal of Pharmaceutical and Biomedical Analysis;2021-09